On this page
CCRN cardiovascular questions turn on a small number of decisions: what to give first, what not to give, and which finding changes the plan. The 13 questions below are built around those decisions for aortic dissection, atrial fibrillation, PSVT, cardiogenic shock and the drugs you hang for them.
They are written for nurses using CCRN exam prep and follow the cardiovascular topics in the CCRN exam domains guide. Each keyed answer rests on a named guideline or FDA label, quoted in our source notes.
This set is exam practice written from the guidelines and FDA drug labels listed under References. The questions are original PrepSolution items, not AACN exam questions. It is not clinical guidance: follow your institution's protocols and the prescriber's orders. It has not been reviewed by a credentialed clinician.
Aortic dissection
Question 1: First drug in acute aortic syndrome
A 62-year-old arrives with tearing chest pain radiating to the back. CT confirms an acute aortic dissection. BP is 178/96 mm Hg and heart rate 104. An arterial line is in place. Which medication class does the 2022 ACC/AHA aortic guideline recommend starting first?
- A. IV nitroprusside
- B. IV hydralazine
- C. Oral ACE inhibitor
- D. IV beta blocker
Best answer: D. The guideline recommends that initial management of acute aortic syndrome include intravenous beta blockers, unless contraindicated, as anti-impulse therapy to decrease aortic wall stress. Vasodilators are added only if blood pressure is not controlled after the beta blocker is started.
- A is not the best answer. The guideline places IV vasodilators after beta blockade, if pressure is still not controlled. Starting a vasodilator alone can raise the heart rate and the force of ejection against the torn wall.
- B is not the best answer. Hydralazine is a vasodilator, so the same order applies, and it is not the recommended first agent.
- C is not the best answer. An oral agent is too slow for an acute syndrome, and the guideline specifies intravenous therapy in an ICU with invasive BP monitoring.
Question 2: Targets for anti-impulse therapy
For the same patient, which pair of targets matches the 2022 aortic guideline?
- A. SBP under 140 mm Hg and heart rate under 100 bpm
- B. SBP under 120 mm Hg (or the lowest that keeps end-organ perfusion) and heart rate 60 to 80 bpm
- C. MAP of at least 65 mm Hg and heart rate under 110 bpm
- D. SBP under 160 mm Hg and heart rate 80 to 100 bpm
Best answer: B. The guideline states that patients with acute aortic syndrome should be treated to an SBP under 120 mm Hg or to the lowest BP that maintains adequate end-organ perfusion, with a target heart rate of 60 to 80 bpm.
- A is not the best answer. These are looser than the guideline targets for an acute dissection.
- C is not the best answer. A MAP of at least 65 mm Hg is a minimum used in septic shock. Dissection management lowers pressure and rate to reduce wall stress.
- D is not the best answer. These targets are far too high for acute aortic syndrome.
Question 3: Type A or type B
A CT report describes a dissection that begins in the aortic arch and extends into the descending thoracic aorta. The ascending aorta is not involved. How is this classified in the Stanford system, as the guideline describes it?
- A. Stanford type A
- B. Neither, because the arch is involved
- C. Stanford type B
- D. Type A, because the tear is proximal to the left subclavian artery
Best answer: C. The guideline's description of the Stanford system puts all dissections involving the ascending aorta in type A, and all that do not involve the ascending aorta in type B, including those that involve the arch but spare the ascending aorta.
- A is not the best answer. Type A requires involvement of the ascending aorta, which is spared here.
- B is not the best answer. The Stanford system covers arch dissections. Arch involvement with a spared ascending aorta is type B.
- D is not the best answer. Stanford classification depends on whether the ascending aorta is involved, regardless of where the intimal tear is.
Question 4: The next step in type A dissection
Imaging shows an acute dissection involving the ascending aorta. The patient is on an esmolol infusion and pain is controlled. What does the guideline recommend?
- A. Emergency surgical consultation and evaluation, with immediate surgical intervention
- B. Admit to the ICU for 48 hours of medical therapy, then reimage
- C. Start anticoagulation to prevent false-lumen thrombosis
- D. Plan elective repair once the aorta reaches a size threshold
Best answer: A. For suspected or confirmed acute type A dissection, the guideline recommends emergency surgical consultation and evaluation and immediate surgical intervention because of the high risk of life-threatening complications. Controlling pressure and pain does not change that.
- B is not the best answer. Medical therapy alone is not the recommended plan for acute type A dissection.
- C is not the best answer. Anticoagulation is not part of the guideline's recommendation here.
- D is not the best answer. Size thresholds guide elective repair of aneurysms, not acute type A dissection.
Atrial fibrillation and other rhythms
Question 5: Unstable atrial fibrillation
A patient in AF with a ventricular rate of 168 becomes confused, with BP 74/40 mm Hg and cool extremities. Which treatment does the 2023 AF guideline call the treatment of choice?
- A. IV diltiazem bolus
- B. Synchronized electrical cardioversion
- C. IV amiodarone infusion
- D. IV digoxin
Best answer: B. The guideline states that in hemodynamically unstable AF, immediate synchronized direct current cardioversion is the treatment of choice, given its rapidity and efficacy. Confusion, hypotension and poor perfusion make this patient unstable.
- A is not the best answer. Rate-control drugs are recommended for hemodynamically stable AF, and diltiazem can worsen hypotension.
- C is not the best answer. Amiodarone converts AF more slowly; the guideline reserves drug cardioversion for stable patients or when electrical cardioversion cannot be done.
- D is not the best answer. Digoxin acts slowly and is not a treatment for unstable AF.
Question 6: Rate control with a weak ventricle
A patient with known severe LV systolic dysfunction (EF 20%) develops AF with a rapid ventricular response. BP is 104/68 mm Hg. Which IV medication does the 2023 AF guideline say should not be given?
- A. Metoprolol
- B. Amiodarone
- C. Magnesium sulfate
- D. Diltiazem
Best answer: D. The guideline gives a Class 3 (Harm) recommendation: in AF with rapid ventricular response and known moderate or severe LV systolic dysfunction, IV nondihydropyridine calcium channel blockers (diltiazem, verapamil) should not be administered. Their negative inotropic effect can worsen heart failure.
- A is not the best answer. Beta blockers are listed for acute rate control in hemodynamically stable AF, and the harm recommendation is specific to nondihydropyridine calcium channel blockers.
- B is not the best answer. The guideline says IV amiodarone may be considered for rate control in critically ill patients or decompensated HF when other agents are ineffective or contraindicated.
- C is not the best answer. The guideline calls adding IV magnesium to standard rate-control measures reasonable.
Question 7: Drug cardioversion and ejection fraction
A stable patient with AF and an LVEF of 30% is being considered for pharmacological cardioversion. The team asks about ibutilide. What does the AF guideline say?
- A. Ibutilide is preferred because it converts AF faster than amiodarone.
- B. Ibutilide is safe at any EF if potassium is normal.
- C. Ibutilide is best avoided when LVEF is 40% or less, because HFrEF is a risk factor for ibutilide-associated torsades de pointes.
- D. Ibutilide may be given only by mouth.
Best answer: C. The guideline notes that ibutilide prolongs the QT interval and that HFrEF is an independent risk factor for ibutilide-associated torsades de pointes, so ibutilide is best avoided in patients with LVEF of 40% or less.
- A is not the best answer. The guideline does say ibutilide converts faster than IV amiodarone, but its recommendation for ibutilide is limited to patients without depressed LV function.
- B is not the best answer. A normal potassium does not remove the torsades risk the guideline ties to reduced EF.
- D is not the best answer. Ibutilide is an intravenous drug in the guideline.
Question 8: Before adenosine
A patient's monitor shows a narrow-complex regular tachycardia at 190 consistent with PSVT. She is alert, BP 118/76 mm Hg. Adenosine is ordered. What does the adenosine label say should be tried first when clinically advisable?
- A. Appropriate vagal maneuvers, such as the Valsalva maneuver
- B. A 12-lead ECG after the dose
- C. Synchronized cardioversion
- D. A beta blocker bolus
Best answer: A. The adenosine label states that when clinically advisable, appropriate vagal maneuvers such as the Valsalva maneuver should be attempted before adenosine is given for PSVT.
- B is not the best answer. Recording the rhythm is good practice, but the label's instruction before the drug is to attempt vagal maneuvers.
- C is not the best answer. She is stable, and cardioversion is not the step the label names before adenosine.
- D is not the best answer. The label does not direct a beta blocker before adenosine.
Question 9: A contraindication to adenosine
Which history makes IV adenosine contraindicated according to its FDA label?
- A. Atrial flutter on a previous ECG
- B. Hypertension treated with amlodipine
- C. A prior episode of PSVT that converted with Valsalva
- D. Second-degree AV block with no functioning pacemaker
Best answer: D. The label lists second- or third-degree AV block as a contraindication, except in patients with a functioning artificial pacemaker. Adenosine works by slowing conduction through the AV node.
- A is not the best answer. The label notes adenosine does not convert atrial flutter, but a history of flutter is not a listed contraindication.
- B is not the best answer. Treated hypertension is not a listed contraindication.
- C is not the best answer. A previous PSVT episode is the kind of rhythm adenosine is indicated for.
Question 10: Hypotension on IV amiodarone
Twenty minutes into an IV amiodarone infusion, a patient's BP falls from 118/70 to 88/50 mm Hg. What does the Nexterone label direct?
- A. Stop the infusion permanently and give calcium chloride
- B. Slow the infusion and, as needed, add vasopressors, positive inotropes and volume expansion
- C. Double the infusion rate to restore sinus rhythm faster
- D. Give a fluid bolus only; the label gives no other direction
Best answer: B. The label's warning for hypotension is to slow the infusion and, as needed, add vasopressor drugs, positive inotropic agents and volume expansion.
- A is not the best answer. The label does not direct calcium chloride or permanent discontinuation for hypotension.
- C is not the best answer. Raising the rate would worsen the problem. The label links higher doses with an increased risk of hypotension.
- D is not the best answer. The label gives specific direction beyond fluid.
Question 11: A lab that raises digoxin risk
A patient on digoxin for rate control has new nausea and yellow-tinged vision. Which lab result does the Lanoxin label name as predisposing to digoxin toxicity?
- A. Sodium 146 mEq/L
- B. Magnesium 2.4 mg/dL
- C. Potassium 3.0 mEq/L
- D. Calcium 8.2 mg/dL
Best answer: C. The label lists low body weight, advanced age, impaired renal function, hypokalemia, hypercalcemia and hypomagnesemia as factors that may predispose to digoxin toxicity. A potassium of 3.0 mEq/L is hypokalemia.
- A is not the best answer. Hypernatremia is not among the factors the label lists.
- B is not the best answer. The label lists hypomagnesemia, and 2.4 mg/dL is not low.
- D is not the best answer. The label lists hypercalcemia, not a low calcium.
Question 12: Nitroglycerin and tamponade
After cardiac surgery a patient has rising filling pressures, falling BP and muffled heart sounds, and cardiac tamponade is suspected. A nitroglycerin infusion is running for blood pressure control. Why does the IV nitroglycerin label list tamponade as a contraindication?
- A. In tamponade cardiac output depends on venous return, which nitroglycerin reduces.
- B. Nitroglycerin causes bleeding into the pericardium.
- C. Nitroglycerin raises pulmonary pressures.
- D. Nitroglycerin is contraindicated only after valve surgery.
Best answer: A. The label explains that in pericardial tamponade, restrictive cardiomyopathy or constrictive pericarditis, cardiac output depends on venous return, and IV nitroglycerin is contraindicated in these conditions. Venodilation reduces the preload the compressed heart relies on.
- B is not the best answer. The label's reason is dependence on venous return, not bleeding.
- C is not the best answer. That is not the reason the label gives.
- D is not the best answer. The contraindication is the condition, tamponade, not the type of surgery.
Question 13: Staging cardiogenic shock
After a large anterior MI, a patient has cool, clammy skin, new confusion and rising lactate, and needs a dobutamine infusion beyond fluids to support perfusion. In the SCAI SHOCK classification, which stage fits?
- A. Stage A, at risk
- B. Stage C, classic
- C. Stage B, beginning
- D. Stage E, extremis
Best answer: B. SCAI defines stage C, classic cardiogenic shock, as a patient with hypoperfusion who requires one intervention, pharmacological or mechanical, beyond volume resuscitation.
- A is not the best answer. Stage A describes a patient at risk without signs or symptoms of cardiogenic shock.
- C is not the best answer. Stage B is hemodynamic instability without hypoperfusion. This patient is hypoperfused.
- D is not the best answer. Stage E is actual or impending circulatory collapse, typically with near pulselessness or ongoing resuscitation.
Where does cardiovascular content sit on the CCRN?
The CCRN Exam Handbook lists cardiovascular as 13% of the Adult CCRN test plan, inside the 80% Clinical Judgment section. Its topic list includes acute coronary syndrome, aortic dissection, cardiac tamponade, cardiogenic shock, dysrhythmias, heart failure, hypertensive crisis and conduction defects. The exam has 150 items, 125 of them scored.
The decisions in this set, side by side
| Situation | What the source says | Source |
|---|---|---|
| Acute aortic syndrome, first drug | IV beta blocker first; add a vasodilator only if BP is still not controlled | 2022 ACC/AHA aortic guideline |
| Acute aortic syndrome, targets | SBP under 120 mm Hg or lowest that keeps perfusion; HR 60 to 80 bpm | 2022 ACC/AHA aortic guideline |
| Acute type A dissection | Emergency surgical consultation and immediate surgery | 2022 ACC/AHA aortic guideline |
| Unstable AF | Immediate synchronized electrical cardioversion | 2023 AF guideline |
| AF with RVR and moderate or severe LV dysfunction | Do not give IV diltiazem or verapamil | 2023 AF guideline |
| Ibutilide | Best avoided when LVEF is 40% or less (torsades risk) | 2023 AF guideline |
| Adenosine | Try vagal maneuvers first when advisable; contraindicated in 2nd or 3rd degree AV block without a pacemaker | FDA label |
| IV amiodarone hypotension | Slow the infusion; add pressors, inotropes, volume as needed | FDA label |
| Digoxin toxicity risk | Hypokalemia, hypercalcemia, hypomagnesemia, renal impairment, age, low weight | FDA label |
| IV nitroglycerin | Contraindicated in tamponade, restrictive cardiomyopathy, constrictive pericarditis | FDA label |
| SCAI stage C | Hypoperfusion needing an intervention beyond volume | SCAI 2022 |
How should you use this set?
Work each question before reading the rationale, and name the rule you used. When you miss one, the fix is usually a sequence (beta blocker before vasodilator) or a contraindication (diltiazem with a weak ventricle, nitroglycerin with tamponade). For more scenario practice across the test plan, see the CCRN clinical judgment questions, and for the full question bank and timed exams, CCRN exam prep.
References
- [1] AACN Certification Corporation (2026). CCRN Exam Handbook, Direct Care (July 2026). AACN Certification Corporation. AACN Certification Corporation
- [2] ACC/AHA (2022). 2022 Guideline for the Diagnosis and Management of Aortic Disease. ACC/AHA. ACC/AHA
- [3] ACC/AHA/ACCP/HRS (2023). 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation. ACC/AHA/ACCP/HRS. ACC/AHA/ACCP/HRS
- [4] SCAI (2022). SHOCK Stage Classification Expert Consensus Update (2022). SCAI. SCAI
- [5] FDA label (2026). Adenosine injection. FDA label. FDA label
- [6] FDA label (2026). Nexterone (amiodarone HCl) premixed injection. FDA label. FDA label
- [7] FDA label (2026). Lanoxin (digoxin) injection. FDA label. FDA label
- [8] FDA label (2026). Nitroglycerin in 5% Dextrose Injection. FDA label. FDA label
Help us improve this guide
How helpful was this article?
One tap helps us understand what’s useful.
Frequently asked questions
The Adult CCRN test plan lists cardiovascular as 13%, within the Clinical Judgment section that makes up 80% of the exam.
The 2022 ACC/AHA aortic guideline recommends an IV beta blocker first, unless contraindicated, with an IV vasodilator added only if blood pressure is not controlled.
The 2022 guideline targets an SBP under 120 mm Hg, or the lowest pressure that maintains end-organ perfusion, and a heart rate of 60 to 80 bpm.
The 2023 AF guideline says IV nondihydropyridine calcium channel blockers should not be given for AF with rapid ventricular response when moderate or severe LV systolic dysfunction is known.
Doses vary by label, indication and protocol. The questions test decisions the sources state directly, not dose calculations.
No. They are original PrepSolution practice items written from the guidelines and FDA labels listed under References. They have not been reviewed by a credentialed clinician and are not clinical guidance.
Keep practicing for the CCRN.
Review the study tools, access options and price, or start with free practice.
Related Articles
CCRN Vasoactive Drips Cheat Sheet: Actions, Uses and Label Warnings
A dose-free cheat sheet of ICU vasoactive infusions from their FDA labels, with 10 CCRN practice questions on actions, labeled uses and the warnings nurses are tested on.
CCRN Respiratory and ABG Practice Questions: 13 With Rationales
Thirteen original CCRN respiratory questions on ARDS ventilation, ABG-driven changes, prone positioning, high-flow oxygen, VAP prevention and sedation, each keyed to a named guideline.
CCRN Exam Domains: What the New Test Plan Changed
AACN's new CCRN test plan took effect November 12, 2025. Cardiovascular fell from 17% to 13%, Respiratory from 15% to 12%, and Musculoskeletal/Neurological/Behavioral climbed from 14% to 18%. Here is every domain weight change and how to reprioritize your study plan.
